Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05647824 · ClinicalTrials.gov registry record
User Performance of the TV4 BGMS
A clinical trial, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- 402
- Enrollment target
NCT05647824 is a clinical trial that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 402 participants.
The verdict
NCT05647824 has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- 402 participants
- Enrollment target
Study Summary
Thunder V4 (TV4) is the code name of a blood glucose monitoring system (BGMS) consisting of a new meter and new Contour FIT test strips. This clinical trial will assess the performance (accuracy) of the TV4 meter by lay users enrolled as subjects in the study, and by health care professionals (also called study staff).
Interventions
- DEVICE Capillary Testing
- DEVICE Alternative Site Testing (AST)
- DEVICE Venous Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 402 participants |
| Start Date | 2020-02-05 |
| Est. Completion | 2020-07-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05647824
The ClinicalTrials.gov registry entry for NCT05647824 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 402 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Capillary Testing is the first listed.
NCT05647824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05647824 about?
NCT05647824 is a clinical study titled "User Performance of the TV4 BGMS". Thunder V4 (TV4) is the code name of a blood glucose monitoring system (BGMS) consisting of a new meter and new Contour FIT test strips. This clinical trial will assess the performance (accuracy) of the TV4 meter by lay users enrolled as subjects in the study, and by health care professionals (also ...
What is the current status of trial NCT05647824?
This trial is currently completed. The enrollment target is 402 participants. The study started on 2020-02-05. Estimated completion is 2020-07-23.
What interventions are being tested in trial NCT05647824?
The interventions under investigation include: Capillary Testing (DEVICE), Alternative Site Testing (AST) (DEVICE), Venous Testing (DEVICE).
Who is sponsoring clinical trial NCT05647824?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.